Moreno, Krissel Mhae .

HRN: 25-11-17  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2024
CEFUROXIME 1.5GM (VIAL)
06/08/2024
06/11/2024
IV
1.5
Q8
S/P Primary CS
Waiting Final Action 
06/08/2024
CEFUROXIME 500MG (TAB)
06/08/2024
06/15/2024
ORAL
500mg
BID
S/p Primary CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: